JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 460 articles

Articles by James Calloway

Deutsche Telekom Shares Dip Amid Buyback Activity Ahead of Key Earnings
Earnings

Deutsche Telekom Shares Dip Amid Buyback Activity Ahead of Key Earnings

Deutsche Telekom shares declined 1.1% to €30.26 despite a €7.63 million share repurchase, with investors focused on upcoming 2025 financial results due February 26.

TMUS
Salesforce Recovers to $191 Amid AI Sector Rotation, Eyes Earnings
Earnings

Salesforce Recovers to $191 Amid AI Sector Rotation, Eyes Earnings

Salesforce shares stabilized at $191.35 Friday, paring weekly losses after an AI-driven selloff hit software stocks. Investors await Q4 results due Feb. 25.

CRM
CBA Shares Hold Ground Ahead of Key Earnings Report
Earnings

CBA Shares Hold Ground Ahead of Key Earnings Report

Commonwealth Bank shares showed relative resilience, declining only 0.23% versus the broader ASX 200's 2.03% drop. Investors await the bank's half-year results and commentary on margin pressures and credit trends.

CBAUF
Abbott Faces Regulatory Scrutiny on Libre Sensors as Insider Buying and New AFib Data Emerge
Regulation

Abbott Faces Regulatory Scrutiny on Libre Sensors as Insider Buying and New AFib Data Emerge

Abbott shares rose 1.6% to $110.83 Friday but remain 21.5% below their 52-week high. The FDA updated a Class I recall for FreeStyle Libre 3 sensors, citing 860 serious injuries and seven deaths, while an insider purchased 10,000 shares.

ABT
Novo Nordisk Shares Rebound as Hims Halts Wegovy Copycat After FDA Pressure
Regulation

Novo Nordisk Shares Rebound as Hims Halts Wegovy Copycat After FDA Pressure

Novo Nordisk's Class B shares surged 5.3% after Hims & Hers discontinued its compounded Wegovy pill following U.S. regulatory warnings. The stock had dropped nearly 8% when the copycat launched.

NVO
Linde Shares Slide on 2026 Guidance, JPMorgan Downgrade
Earnings

Linde Shares Slide on 2026 Guidance, JPMorgan Downgrade

Linde stock fell 2.5% after issuing 2026 EPS guidance below consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets.

LIN
Citigroup Surges 6% on Regulatory Progress, Eyes Key Data and Conferences
Regulation

Citigroup Surges 6% on Regulatory Progress, Eyes Key Data and Conferences

Citigroup shares rallied 6% Friday amid optimism over resolving long-standing consent orders. The bank also announced a $2.3 billion preferred stock redemption and employee account matching.

C BAC WFC JPM GS XLK XLF
T-Mobile Shares Dip Ahead of Key Financial Outlook and Earnings Report
Earnings

T-Mobile Shares Dip Ahead of Key Financial Outlook and Earnings Report

T-Mobile US stock declined 2.2% to $197.39 Friday, underperforming the broader market as investors await the company's updated 2026-27 targets and Q4 earnings on Feb. 11.

TMUS VZ
Shell Announces Auditor Switch, Kazakhstan Investment Pause Amid Ongoing Buybacks
Regulation

Shell Announces Auditor Switch, Kazakhstan Investment Pause Amid Ongoing Buybacks

Shell has selected PwC as its new auditor starting in 2027 and will halt new investments in Kazakhstan due to legal disputes. The company continues its share repurchase program.

SHEL
SAP Treasury Holdings Surpass 5% as €2.6 Billion Buyback Program Commences
Earnings

SAP Treasury Holdings Surpass 5% as €2.6 Billion Buyback Program Commences

SAP's treasury stock has exceeded 5% of share capital following the launch of a €2.6 billion share repurchase program. Investors are now looking ahead to the company's Integrated Report later this month.

SAP
L'Oréal Shares Dip Ahead of Annual Earnings Release
Earnings

L'Oréal Shares Dip Ahead of Annual Earnings Release

L'Oréal shares edged lower Friday, extending losses as investors await the cosmetics giant's 2025 annual results next week. The stock traded 319,000 shares in a tight range while the broader STOXX 600 gained.

LRLCY
IHC Issues Phishing Alert as Shares Hold Steady Near 400 Dirhams
Regulation

IHC Issues Phishing Alert as Shares Hold Steady Near 400 Dirhams

International Holding Company warns investors of fraudulent emails using its branding, while its stock trades flat at 399.60 dirhams. UAE equities edged higher amid focus on geopolitics and oil.

FXI